136 related articles for article (PubMed ID: 19895945)
1. Novel targets that affect high-density lipoprotein metabolism: the next frontier.
Davidson MH; Rosenson RS
Am J Cardiol; 2009 Nov; 104(10 Suppl):52E-7E. PubMed ID: 19895945
[TBL] [Abstract][Full Text] [Related]
2. High-density lipoprotein metabolism: potential therapeutic targets.
Davidson MH; Toth PP
Am J Cardiol; 2007 Dec; 100(11 A):n32-40. PubMed ID: 18047851
[TBL] [Abstract][Full Text] [Related]
3. Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels.
Hausenloy DJ; Yellon DM
Heart; 2008 Jun; 94(6):706-14. PubMed ID: 18480348
[TBL] [Abstract][Full Text] [Related]
4. The importance of recognizing and treating low levels of high-density lipoprotein cholesterol: a new era in atherosclerosis management.
Cardenas GA; Lavie CJ; Cardenas V; Milani RV; McCullough PA
Rev Cardiovasc Med; 2008; 9(4):239-58. PubMed ID: 19122582
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of high-density lipoprotein cholesterol-increasing compounds: a meta-analysis of randomized controlled trials.
Birjmohun RS; Hutten BA; Kastelein JJ; Stroes ES
J Am Coll Cardiol; 2005 Jan; 45(2):185-97. PubMed ID: 15653014
[TBL] [Abstract][Full Text] [Related]
6. Raising high-density lipoprotein cholesterol with reduction of cardiovascular risk: the role of nicotinic acid--a position paper developed by the European Consensus Panel on HDL-C.
Chapman MJ; Assmann G; Fruchart JC; Shepherd J; Sirtori C;
Curr Med Res Opin; 2004 Aug; 20(8):1253-68. PubMed ID: 15324528
[TBL] [Abstract][Full Text] [Related]
7. Modifying plasma low-density lipoprotein and high-density lipoprotein cholesterol: what combinations are available in the future?
Kastelein JJ
Am J Cardiol; 2005 Nov; 96(9A):20K-27K; discussion 34K-35K. PubMed ID: 16291010
[TBL] [Abstract][Full Text] [Related]
8. Effects of modifying triglycerides and triglyceride-rich lipoproteins on cardiovascular outcomes.
Abdel-Maksoud M; Sazonov V; Gutkin SW; Hokanson JE
J Cardiovasc Pharmacol; 2008 Apr; 51(4):331-51. PubMed ID: 18427276
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of CETP as a novel therapeutic strategy for reducing the risk of atherosclerotic disease.
Shah PK
Eur Heart J; 2007 Jan; 28(1):5-12. PubMed ID: 17121756
[TBL] [Abstract][Full Text] [Related]
10. Bibliography. Current world literature. HDL cholesterol.
Curr Opin Cardiol; 2008 Jul; 23(4):426-9. PubMed ID: 18536113
[No Abstract] [Full Text] [Related]
11. High-density lipoproteins: multifunctional vanguards of the cardiovascular system.
Marcil M; O'Connell B; Krimbou L; Genest J
Expert Rev Cardiovasc Ther; 2004 May; 2(3):417-30. PubMed ID: 15151487
[TBL] [Abstract][Full Text] [Related]
12. High-density lipoprotein as a therapeutic target: clinical evidence and treatment strategies.
Toth PP
Am J Cardiol; 2005 Nov; 96(9A):50K-58K; discussion 34K-35K. PubMed ID: 16291015
[TBL] [Abstract][Full Text] [Related]
13. The treatment of dyslipidemia--what's left in the pipeline?
Rau O; Zettl H; Popescu L; Steinhilber D; Schubert-Zsilavecz M
ChemMedChem; 2008 Feb; 3(2):206-21. PubMed ID: 17963209
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of combination of extended release niacin and atorvastatin in patients with low levels of high density lipoprotein cholesterol.
Harikrishnan S; Rajeev E; Tharakan JA; Titus T; Ajit Kumar VK; Sivasankaran S; Krishnamoorthy KM; Nair K
Indian Heart J; 2008; 60(3):215-22. PubMed ID: 19240310
[TBL] [Abstract][Full Text] [Related]
15. Patients with low levels of high-density lipoprotein cholesterol: to treat or not to treat?
Tavintharan S; Lim SC; Sum CF
Singapore Med J; 2005 Oct; 46(10):519-28. PubMed ID: 16172771
[TBL] [Abstract][Full Text] [Related]
16. Evidence to support aggressive management of high-density lipoprotein cholesterol: implications of recent imaging trials.
Taylor AJ
Am J Cardiol; 2008 Apr; 101(8A):36B-43B. PubMed ID: 18375240
[TBL] [Abstract][Full Text] [Related]
17. Refocusing on use of cholesteryl ester transfer protein inhibitors.
Kastelein JJ
Am J Cardiol; 2007 Dec; 100(11 A):n47-52. PubMed ID: 18047853
[TBL] [Abstract][Full Text] [Related]
18. Targeting cardiovascular risk associated with both low density and high density lipoproteins using statin-niacin combination therapy.
Duvall WL; Blazing MA; Saxena S; Guyton JR
J Cardiovasc Risk; 2002 Dec; 9(6):339-47. PubMed ID: 12478203
[TBL] [Abstract][Full Text] [Related]
19. High-density lipoprotein cholesterol: current perspective for clinicians.
Whayne TF
Angiology; 2009; 60(5):644-9. PubMed ID: 19240106
[TBL] [Abstract][Full Text] [Related]
20. Dyslipidaemia in diabetic patients: time for a rethink.
Shepherd J
Diabetes Obes Metab; 2007 Sep; 9(5):609-16. PubMed ID: 17697054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]